Equities

MEI Pharma Inc

0JW9:LSE

MEI Pharma Inc

Actions
  • Price (USD)2.80
  • Today's Change2.80 / --
  • Shares traded1.00k
  • 1 Year change-52.26%
  • Beta--
Data delayed at least 20 minutes, as of Nov 20 2024 15:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments38101153
Total Receivables, Net00.0910
Total Inventory------
Prepaid expenses2.426.753.83
Other current assets, total------
Total current assets41108167
Property, plant & equipment, net0.611311
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets41121178
LIABILITIES
Accounts payable3.176.137.92
Accrued expenses5.191412
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total00.324.83
Total current liabilities8.362024
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total076101
Total liabilities8.3696125
SHAREHOLDERS EQUITY
Common stock000
Additional paid-in capital421431427
Retained earnings (accumulated deficit)(388)(406)(374)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total000
Total equity332552
Total liabilities & shareholders' equity41121178
Total common shares outstanding6.666.666.66
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.